Triple therapy including once-daily emtricitabine effective in HIV

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1278, 2001-01, pp. : 9-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emtricitabine: a new nucleoside analogue for once-daily antiretroviral therapy

By Cahn Pedro

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 1, 2004-01 ,pp. : 55-68

Informa Healthcare

Access to resources Recommend Favorite

Treatment of HIV infection with once-daily regimens

By Permpalung Nitipong Putcharoen Opass Avihingsanon Anchalee Ruxrungtham Kiat

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 16, 2012-11 ,pp. : 2301-2317

Informa Healthcare

Access to resources Recommend Favorite

Elvitegravir: a once-daily inhibitor of HIV-1 integrase

By Wills Todd Vega Vivian

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 3, 2012-03 ,pp. : 395-401

Informa Healthcare

Access to resources Recommend Favorite

Long-term efficacy of a novel, once-daily triple NRTI regimen

Inpharma, Vol. 1, Iss. 1600, 2007-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Emtricitabine effective in paediatric HIV infections

Inpharma, Vol. 1, Iss. 1380, 2003-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite